Nuveen Asset Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $13,946 - $22,304	2,309 Added 2.31%	102,103 $768,000
Q2 2022 Aug 15, 2022	SELL	$4.99 - $8.96 $73,687 - $132,312	-14,767 Reduced 12.89%	99,794 $629,000
Q1 2022 May 16, 2022	SELL	$3.84 - $9.74 $17,379 - $44,083	-4,526 Reduced 3.8%	114,561 $990,000
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $65,832 - $105,307	-12,858 Reduced 9.74%	119,087 $631,000
Q3 2021 Nov 12, 2021	BUY	$6.68 - $9.1 $14,635 - $19,938	2,191 Added 1.69%	131,945 $952,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.23 $139,313 - $164,432	17,815 Added 15.91%	129,754 $1.11 Million
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $33,515 - $50,272	-3,971 Reduced 3.43%	111,939 $991,000
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $156,719 - $241,363	19,639 Added 20.4%	115,910 $1.42 Million
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $3,430 - $5,353	431 Added 0.45%	96,271 $783,000
Q2 2020 Aug 14, 2020	SELL	$5.4 - $13.37 $749,655 - $1.86 Million	-138,825 Reduced 59.16%	95,840 $920,000
Q1 2020 May 14, 2020	BUY	$4.91 - $14.7 $764,182 - $2.29 Million	155,638 Added 196.94%	234,665 $1.6 Million
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $189,020 - $302,974	19,347 Added 32.42%	79,027 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $358,666 - $448,800	-37,400 Reduced 38.52%	59,680 $611,000
Q2 2019 Aug 15, 2019	BUY	$9.54 - $14.96 $926,143 - $1.45 Million	97,080 New	97,080 $1.03 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.